Pzena Investment Management LLC Buys New Stake in Concentrix Corporation $CNXC

Pzena Investment Management LLC purchased a new stake in Concentrix Corporation (NASDAQ:CNXC) during the second quarter, according to its most recent filing with the SEC. The fund purchased 3,413,879 shares of the company’s stock, valued at approximately $76,488,000. Pzena Investment Management LLC owned about 5.59% of Concentrix as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the last quarter. Larson Financial Group LLC grew its holdings in Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares in the last quarter. Global Retirement Partners LLC grew its holdings in Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock valued at $36,000 after buying an additional 795 shares in the last quarter. Rothschild Investment LLC increased its stake in Concentrix by 52.0% in the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock worth $48,000 after acquiring an additional 392 shares during the last quarter. Finally, AlphaCore Capital LLC increased its stake in Concentrix by 1,962.1% in the 4th quarter. AlphaCore Capital LLC now owns 1,196 shares of the company’s stock worth $50,000 after acquiring an additional 1,138 shares during the last quarter. Institutional investors own 90.34% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on CNXC shares. Zacks Research downgraded Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Robert W. Baird reduced their price target on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Canaccord Genuity Group decreased their price target on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Finally, Barrington Research dropped their price objective on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $32.75.

Concentrix Stock Down 4.7%

NASDAQ:CNXC opened at $23.33 on Tuesday. Concentrix Corporation has a twelve month low of $19.12 and a twelve month high of $57.88. The company has a market cap of $1.42 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 0.45 and a beta of 0.45. The stock has a fifty day simple moving average of $24.53 and a 200-day simple moving average of $27.81. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXC) last issued its earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.70 earnings per share. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Analysts anticipate that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th were given a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend was Friday, July 24th. Concentrix’s payout ratio is -6.75%.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.